相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Safety Concerns With Proton Pump Inhibitors
Joan Chen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies
L. Laine et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers
G. Morelli et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Conformational rearrangement of gastric H+,K+-ATPase induced by an acid suppressant
Kazuhiro Abe et al.
NATURE COMMUNICATIONS (2011)
Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg
Michael Kukulka et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2011)
Inter-subunit interaction of gastric H+,K+-ATPase prevents reverse reaction of the transport cycle
Kazuhiro Abe et al.
EMBO JOURNAL (2009)
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shaojun Shi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms
P. O. Katz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Functional consequences of the oligomeric form of the membrane-bound gastric H,K-ATPase
JM Shin et al.
BIOCHEMISTRY (2005)
A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease
DA Johnson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
The cavity structure for docking the K+-competitive inhibitors in the gastric proton pump
S Asano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study
PO Katz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo
JM Shin et al.
BIOCHEMICAL PHARMACOLOGY (2004)
CYPC19 polymorphism and proton pump inhibitors
U Klotz et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2004)
Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors
JM Shin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms
K Röhss et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers
CH Wilder-Smith et al.
DIGESTION (2003)
Restoration of acid secretion following treatment with proton pump inhibitors
JM Shin et al.
GASTROENTEROLOGY (2002)
The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH
O Junghard et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Selective Fe2+-catalyzed oxidative cleavage of gastric H+,K+-ATPase -: Implications for the energy transduction mechanism of P-type cation pumps
JM Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole
T Andersson et al.
CLINICAL PHARMACOKINETICS (2001)
Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors
CAM Stedman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
